Evaluation of ADL in patients with Hunter disease using FIM score

Brain and Development

Volumn 29, Issue 5, 2007, Pages 298-305

  Kato, Tomomi ^a,b   Kato, Zenichiro ^a,c   Kuratsubo, Izumi ^a   Ota, Tetsuo ^d   Orii, Tadao ^e   Kondo, Naomi ^a,c   Suzuki, Yasuyuki ^a,b  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d CHUBU GAKUIN UNIVERSITY   (Japan)

^e KEIO UNIVERSITY   (Japan)

Author keywords

Activities of daily life; ADL; FIM; Functional independent measure; Hunter disease; Mucopolysaccharidosis type II

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EDUCATIONAL STATUS; FAMILY; FUNCTIONAL INDEPENDENCE MEASURE; HEALTH STATUS; HUMAN; HUNTER SYNDROME; JAPANESE; MALE; MOTOR PERFORMANCE; PHENOTYPE; QUALITY OF LIFE;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGING; AUDIOMETRY, PURE-TONE; CHILD; CHILD, PRESCHOOL; COGNITION; HIP JOINT; HUMANS; INTELLIGENCE TESTS; JAPAN; MALE; MUCOPOLYSACCHARIDOSIS II; PHENOTYPE; PSYCHOMETRICS; RANGE OF MOTION, ARTICULAR; SHOULDER JOINT; URINARY BLADDER DISEASES;

EID: 33947601413     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2006.08.015     Document Type: Article

References (19)

1. Neufeld F., and Muenzer J. The mucopolysaccharidoses. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The metabolic and molecular bases of inherited disease. 8th ed. (2001), McGraw-Hill, New York 3421-3452
2. Young I.D., and Harper P.S. The natural history of the severe form of Hunter's syndrome: a study based on 52 cases. Dev Med Child Neural 25 (1983) 481-489
3. Hiraizumi Y. A clinical and biochemical study of Hunter's syndrome. Acta Sch Med Univ Gifu 37 (1989) 343-377
4. Kato T., Kato Z., Kuratsubo I., Tanaka N., Ishigami T., Kajihara J., et al. Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II. J Hum Genet 50 (2005) 395-402
5. Keith R.A., Granger C.V., Hamilton B.B., and Sherwin F.S. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil 1 (1987) 6-18
6. Granger C.V., Hamilton B.B., Linacre J.M., Heinemann A.W., and Wright B.D. Performance profiles of the functional independence measure. Am J Phys Med Rehabil 72 (1993) 84-89
7. Cotter E.M., Burgio L.D., Stevens A.B., Roth D.L., and Gitlin L.N. Correspondence of the functional independence measure (FIM) self-care subscale with real-time observations of dementia patients' ADL performance in the home. Clin Rehabil 16 (2002) 36-45
8. Granger C.V., Wende K., and Brownscheidle C.M. Use of the FIM instrument in a trial of intramuscular interferon beta-1a for disease progression in relapsing-remitting multiple sclerosis. Am J Phys Med Rehabil 82 (2003) 427-436
9. Ota T., Domen K., Liu M., and Chino N. A trial of scoring the functional independence measure using questionnaire (in Japanese). Sogo Riha 25 (1997) 449-454
10. Ota T, Domen K, Liu M, Sonoda S, Chino N. Scoring the functional independence measure using a questionnaire. World Congress of the International Rehabilitation Medicine Association (8th) 1997; Abstracts: 374.
11. Chang W.C., Slaughter S., Cartwright D., and Chan C. Evaluating the FONE FIM: Part I. Construct validity. J Outcome Meas 1 (1997) 192-218
12. Sukegawa K., Tomatsu S., Tamai K., Ikeda M., Sasaki T., Masue M., et al. Intermediate form of mucopolysaccharidosis type II (Hunter disease): a C1327 to T substitution in the iduronate sulfatase gene. Biochem Biophys Res Commun 183 (1992) 809-813
13. Wilson P.J., Morris C.P., Anson D.S., Occhiodoro T., Bielicki J., Clements P.R., et al. Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci USA 87 (1990) 8531-8535
14. Yamada Y., Tomatsu S., Sukegawa K., Suzuki Y., Kondo N., Hopewood J.J., et al. Mucopolysaccharidosis type II (Hunter disease): 13 gene mutations in 52 Japanese patients and carrier detection in four families. Hum Genet 92 (1993) 110-111
15. lsogai K., Sukegawa K., Tomatsu S., Fukao T., Song X.-Q., Yamada Y., et al. Mutation analysis in the iduronate-2-sulfatase gene in 43 Japanese patients with mucopolysaccharidosis type II (Hunter disease). J Inherit Metab Dis 21 (1998) 60-70
16. Chang J.H., Lin S.P., Lin S.C., Tseng K.L., Li C.L., Chuang C.K., et al. Expression studies of mutations underlying Taiwanese Hunter syndrome (mucopolysaccharidosis type II). Hum Genet 116 (2005) 160-166
17. Kurihara M., Nakae Y., Kohagisawa T., Kumagai K., and Eto Y. Investigation to sequelae of acute encephalopathy (in Japanese). No To Hattatsu 33 (2001) 392-399
18. Colvin L., Fyfe S., Leonard S., Schiavello T., Ellaway C., De Klerk N., et al. Describing the phenotype in Rett syndrome using a population database. Arch Dis Child 88 (2003) 38-43
19. Chung B.H., Wong V.C., and Ip P. Spinal muscular atrophy: survival pattern and functional status. Pediatrics 114 (2004) e548-e553